AtriCure
ATRC
141 hedge funds and large institutions have $872M invested in AtriCure in 2019 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 54 increasing their positions, 50 reducing their positions, and 19 closing their positions.
8% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 50
0.68% less ownership
Funds ownership: 89.24% → 88.56% (-0.68%)
3% less funds holding
Funds holding: 145 → 141 (-4)
15% less capital invested
Capital invested by funds: $1.03B → $872M (-$157M)
16% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 19
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
58% less call options, than puts
Call options by funds: $962K | Put options by funds: $2.27M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$19.3M |
| 2 |
SAM
Silvercrest Asset Management
New York
|
+$9.16M |
| 3 |
DM
Deerfield Management
New York
|
+$8.36M |
| 4 |
BlackRock
New York
|
+$7.08M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$5.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$12.2M |
| 2 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$10.8M |
| 3 |
RA
Royce & Associates
New York
|
-$7.17M |
| 4 |
FI
Fosun International
Hong Kong,
China
|
-$5.91M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$5.27M |
ATRC Hedge Fund Activity: Q3 2019 in Review
141 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q3 2019, worth a combined $872M — down 15% from $1.03B a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of ATRC and 16 opened new positions — a net loss of 3 holders — while 50 trimmed existing stakes and 54 added.
The largest buyer was Champlain Investment Partners, opening a new position worth an estimated $19.3M. The largest seller was Hood River Capital Management, exiting entirely with an estimated $12.2M sold.
- 141 institutional investors held AtriCure (ATRC) as of Q3 2019, down from 145 in Q2 2019.
- Funds reported $872M of AtriCure stock for Q3 2019, down 15% quarter-over-quarter.
- 16 funds opened new AtriCure positions in Q3 2019 and 19 closed out, a net change of -3 holders.
- The largest AtriCure buyer in Q3 2019 was Champlain Investment Partners, an estimated $19.3M added.
- The largest AtriCure seller in Q3 2019 was Hood River Capital Management, an estimated $12.2M sold.
Based on aggregated 13F filings for Q3 2019.